UPDATE 1-Shire wins U.S. approval for long-acting ADHD drug

* Shares up 1.5 percent in London trading (Adds sales forecasts, shares, reaction)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.